EPISODE #145 Medical Cannabis and Pharmaceuticals with Paul Steckler, Managing Director for Canopy Growth International
In our latest episode, we’re joined by Paul Steckler, Managing Director for Canopy Growth International. We discuss the challenges of fitting cannabis production into a traditional pharmaceutical medical framework, along with some of the biggest UK-centric, economic and market challenges associated with operating within this space.
📚 VIEW SHOW NOTES AND EXTRAS:
About Paul Steckler
Paul Steckler is the Managing Director for Canopy Growth in international markets including Europe and APAC. Paul is a seasoned pharmaceutical executive with over 20 years’ experience in commercial roles, having worked in both large and small pharmaceutical companies.
In his 15 years as Commercial Director at Pfizer, Paul successfully grew specialty brands from pre-launch to loss of exclusivity. Additionally, Paul oversaw a successful IPO while Chief Commercial Officer at Shield Therapeutics Plc., a London listed AIM specialty research-based pharmaceutical company, while simultaneously overseeing leading global commercial operations. Paul is also an eco-conscious vegetarian, avid cyclist and football coach.
The industry is quite new, and it's exciting. It's entrepreneurial. Everyone is kind of learning as they go along
Canopy Growth’s Website: https://www.canopygrowth.com/
Follow Paul on LinkedIn: https://www.linkedin.com/in/paulsteckler/?originalSubdomain=uk
Follow on LinkedIn: https://www.linkedin.com/company/canopy-growth-corporation/